1. Aguilar, P. S. et al. Genetic basis of cell-cell fusion mechanisms. Trends Genet. 29, 427–437 (2013).
2. Bastida-Ruiz, D., Van Hoesen, K. & Cohen, M. The dark side of cell fusion. Int. J. Mol. Sci. 17, https://doi.org/10.3390/ijms17050638 (2016).
3. Benirschke, K., Burton, G. J.& Baergen, R. N. In Pathology of the Human Placenta 249–307 (Springer Berlin Heidelberg, 2012).
4. Simpson, R. A., Mayhew, T. M. & Barnes, P. R. From 13 weeks to term, the trophoblast of human placenta grows by the continuous recruitment of new proliferative units: a study of nuclear number using the disector. Placenta 13, 501–512 (1992).
5. Fitzgerald, B. et al. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 32, 339–345 (2011).
6. Gauster, M., Moser, G., Orendi, K. & Huppertz, B. Factors involved in regulating trophoblast fusion: potential role in the development of preeclampsia. Pla- centa 30(Suppl A), S49–S54 (2009).
7. Ishihara, N. et al. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am. J. Obstet. Gynecol. 186, 158–166 (2002).
8. Huppertz, B. et al. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab. Invest. 79, 1687–1702 (1999).
9. Huppertz, B. et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 24, 181–190 (2003).
10. Ellery, P. M., Cindrova-Davies, T., Jauniaux, E., Ferguson-Smith, A. C. & Burton, G. J. Evidence for transcriptional activity in the syncytiotrophoblast of the human placenta. Placenta 30, 329–334 (2009).
11. Görisch, S. M., Wachsmuth, M., Tóth, K. F., Lichter, P. & Rippe, K. Histone acetylation increases chromatin accessibility. J. Cell Sci. 118, 5825–5834 (2005).
12. Gallinari, P., Di Marco, S., Jones, P., Pallaoro, M.& Steinkühler, C. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell Res. 17, 195–211 (2007).
13. Wang, Z. et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138, 1019–1031 (2009).
14. de Ruijter, A. J. M., van Gennip, A. H., Caron, H. N., Kemp, S.& van Kuilenburg, A. B. P. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737–749 (2003).
15. Fischle, W. et al. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274, 11713–11720 (1999).
16. Lehrmann, H., Pritchard, L. L. & Harel-Bellan, A. Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv. Cancer Res. 86, 41–65 (2002).
17. LeBoeuf, M. et al. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev. Cell 19, 807–818 (2010).
18. Lee, J.-H., Hart, S. R. L. & Skalnik, D. G. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 38, 32–38 (2004).
19. Kidder, B. L. & Palmer, S. HDAC1 regulates pluripotency and lineage specific transcriptional networks in embryonic and trophoblast stem cells. Nucleic Acids Res. 40, 2925–2939 (2012).
20. Maltepe, E. et al. Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta. Development 132, 3393–3403 (2005).
21. Pan, Z. et al. Impaired placental trophoblast lineage differentiation in Alkbh1 (-/-) mice. Dev. Dyn. 237, 316–327 (2008).
22. Arul Nambi Rajan, K. et al. Sirtuin1 is required for proper trophoblast differ- entiation and placental development in mice. Placenta 62, 1–8 (2018).
23. Duan, H. et al. HDAC2 was involved in placental P-glycoprotein regulation both in vitro and vivo. Placenta 58, 105–114 (2017).
24. Togher, K. L., Kenny, L. C. & O’Keeffe, G. W. Class-specific histone deacetylase inhibitors promote 11-beta hydroxysteroid dehydrogenase type 2 expression in JEG-3 cells. Int. J. Cell Biol. 2017, 6169310 (2017).
25. Okae, H. et al. Derivation of human trophoblast stem cells. Cell Stem Cell 22, 50–63.e6 (2018).
26. Kwak, Y.-T., Muralimanoharan, S., Gogate, A. A. & Mendelson, C. R. Human trophoblast differentiation is associated with profound gene regulatory and epigenetic changes. Endocrinology 160, 2189–2203 (2019).
27. Than, N. G. et al. Evolutionary origins of the placental expression of chro- mosome 19 cluster galectins and their complex dysregulation in pre- eclampsia. Placenta 35, 855–865 (2014).
28. Lo, H.-F. et al. Association of dysfunctional synapse defective 1 (SYDE1) with restricted fetal growth - SYDE1 regulates placental cell migration and invasion. J. Pathol. 241, 324–336 (2017).
29. Tian, G. et al. Expression and function of the LIM homeobox containing genes Lhx3 and Lhx4 in the mouse placenta. Dev. Dyn. 237, 1517–1525 (2008).
30. Jurkin, J. et al. Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis. Cell Cycle 10, 406–412 (2011).
31. Montgomery, R. L. et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 21, 1790–1802 (2007).
32. Baines, K. J. & Renaud, S. J. Transcription factors that regulate trophoblast development and function. Prog. Mol. Biol. Transl. Sci. 145, 39–88 (2017).
33. Nieto, M. A., Huang, R. Y.-J., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21–45 (2016).
34. Voon, D. C., Huang, R. Y., Jackson, R. A. & Thiery, J. P. The EMT spectrum and therapeutic opportunities. Mol. Oncol. 11, 878–891 (2017).
35. Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest 119, 1429–1437 (2009).
36. Abell, A. N. et al. MAP3K4/CBP-regulated H2B acetylation controls epithelial- mesenchymal transition in trophoblast stem cells. Cell Stem Cell 8, 525–537 (2011).
37. Denslow, S. A. & Wade, P. A. The human Mi-2/NuRD complex and gene regulation. Oncogene 26, 5433–5438 (2007).
38. Lee, M. G., Wynder, C., Cooch, N. & Shiekhattar, R. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437, 432–435 (2005).
39. Silverstein, R. A.& Ekwall, K. Sin3: a flexible regulator of global gene expression and genome stability. Curr. Genet. 47, 1–17 (2005).
40. Yamaguchi, T. et al. Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 24, 455–469 (2010).
41. Dovey, O. M. et al. Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice. Blood 121, 1335–1344 (2013).
42. Thambyrajah, R. et al. HDAC1 and HDAC2 modulate TGF-β signaling during endothelial-to-hematopoietic transition. Stem Cell Rep. 10, 1369–1383 (2018).
43. Montgomery, R. L., Hsieh, J., Barbosa, A. C., Richardson, J. A. & Olson, E. N. Histone deacetylases 1 and 2 control the progression of neural precursors to neurons during brain development. Proc. Natl Acad. Sci. USA 106, 7876–7881 (2009).
44. Jacob, C. et al. HDAC1 and HDAC2 control the specification of neural crest cells into peripheral glia. J. Neurosci. 34, 6112–6122 (2014).
45. Karolczak-Bayatti, M., Loughney, A. D., Robson, S. C. & Europe-Finner, G. N. Epigenetic modulation of the protein kinase A RIIα (PRKAR2A) gene by his- tone deacetylases 1 and 2 in human smooth muscle cells. J. Cell Mol. Med. 15, 94–108 (2011).
46. Ye, F. et al. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nat. Neurosci. 12, 829–838 (2009).
47. Jamaladdin, S. et al. Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells. Proc. Natl Acad. Sci. USA 111, 9840–9845 (2014).
48. Lagger, G. et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 21, 2672–2681 (2002).
49. Lin, C.-L. et al. HDAC1 and HDAC2 double knockout triggers cell apoptosis in advanced thyroid cancer. Int. J. Mol. Sci. 20, https://doi.org/10.3390/ ijms20020454 (2019).
50. Wilting, R. H. et al. Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J. 29, 2586–2597 (2010).
51. Kliman, H. J., Nestler, J. E., Sermasi, E., Sanger, J. M. & Strauss, J. F. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118, 1567–1582 (1986).
52. Wice, B., Menton, D., Geuze, H. & Schwartz, A. L. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp. Cell Res. 186, 306–316 (1990).
53. Renaud, S. J. et al. OVO-like 1 regulates progenitor cell fate in human tro- phoblast development. Proc. Natl Acad. Sci. USA 112, E6175–E6184 (2015).
54. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
55. Willems, E., Leyns, L. & Vandesompele, J. Standardization of real-time PCR gene expression data from independent biological replicates. Anal. Biochem. 379, 127–129 (2008).
56. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10 (2011).
57. Haeussler, M. et al. The UCSC Genome Browser database: 2019 update. Nucleic Acids Res. 47, D853–D858 (2019).
58. Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915 (2019).
59. Ramírez, F. et al. deepTools2: a next generation web server for deep- sequencing data analysis. Nucleic Acids Res. 44, W160–5 (2016).
60. Lun, A. T. L. & Smyth, G. K. csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows. Nucleic Acids Res. 44, e45 (2016).
61. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
62. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc.: Ser. B (Methodol.) 57, 289–300 (1995).
63. Ignatiadis, N., Klaus, B., Zaugg, J. B. & Huber, W. Data-driven hypothesis weighting increases detection power in genome-scale multiple testing. Nat. Methods 13, 577–580 (2016).
64. Barrett, T. et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 41, D991–5 (2013).
65. Renaud, S. J., Kubota, K., Rumi, M. A. K. & Soares, M. J. The FOS transcription factor family differentially controls trophoblast migration and invasion. J. Biol. Chem. 289, 5025–5039 (2014).
66. Boskovic, Z. V. et al. Inhibition of zinc-dependent histone deacetylases with a chemically triggered electrophile. ACS Chem. Biol. 11, 1844–1851 (2016).
67. Furumai, R. et al. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. Cancer Res. 62, 4916–4921 (2002).
68. Pavlik, C. M. et al. Santacruzamate A, a potent and selective histone deace- tylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp. J. Nat. Prod. 76, 2026–2033 (2013).
69. Marek, L. et al. Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. J. Med. Chem. 56, 427–436 (2013).
70. Saito, A. et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl Acad. Sci. USA 96, 4592–4597 (1999).
71. Malvaez, M. et al. HDAC3-selective inhibitor enhances extinction of cocaine- seeking behavior in a persistent manner. Proc. Natl Acad. Sci. USA 110, 2647–2652 (2013).
72. Richon, V. M. et al. A class of hybrid polar inducers of transformed cell dif- ferentiation inhibits histone deacetylases. Proc. Natl Acad. Sci. USA 95, 3003–3007 (1998).
73. Vigushin, D. M. et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin. Cancer Res. 7, 971–976 (2001).
論文の公開元へ
